甲基胺蛋白质糖化疗法的免疫后果
Tobin J Dickerson1, Noboru Yamamoto, Diana I Ruiz
1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Journal of the American Chemical Society
|September 16, 2004
概括
甲基胺会导致蛋白质糖化异常,在小鼠中引发强烈的免疫反应. 关键抗体标涉及药物和葡萄糖衍生的修饰,这表明对药物成的影响.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 滥用药物甲基胺与异常的蛋白质糖化有关.
- 蛋白质糖化可以导致具有改变功能的修饰蛋白质的形成.
研究的目的:
- 为了研究对甲基胺修饰蛋白质的免疫反应.
- 通过针对这些修饰蛋白质产生的抗体识别的表位的特征.
主要方法:
- 用甲基胺修改小鼠专蛋白.
- 用修改的白蛋白免疫小鼠.
- 分析抗体结合的竞争实验.
主要成果:
- 在没有辅助剂的情况下,注射甲基胺修饰的白蛋白诱导了显著的免疫反应.
- 针对改性白蛋白产生的抗体识别了一种表位,包括甲基胺和葡萄糖衍生的区域.
- 甲基胺与引起的抗体的结合是弱的,但表位是关键的.
结论:
- 甲基胺对蛋白质的异常糖化可以引起大量的免疫反应.
- 免疫反应的目标是一个复杂的表位,涉及药物和糖化产品.
- 这种现象可能对理解药物成的免疫病理学有影响.
相关概念视频
Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...


